CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The ASX 200 (INDEXASX:XJO) is set to open lower on Thursday. Premier Investments (ASX:PMV) and GrainCorp (ASX:GNC) shares are in the news.
In my opinion, ASX growth shares might be the best way to make good money from the share market over the long-term.
The ASX 200 (INDEXASX:XJO) is set to open lower on Friday. Qantas Airways (ASX:QAN) and Cleanaway Waste Management (ASX:CWY) shares are making headlines.
Is there still good value to be found in the ASX large-cap space? I think so – here are my top three large-cap shares I like at the moment.
BHP Group (ASX:BHP) are often considered as the backbone of a balanced ASX portfolio. Here’s what I think…
Vanguard Australian Shares Index ETF (ASX:VAS) is one of the most popular exchange traded funds (ETFs) on the ASX. Is it a good time to buy?
There are couple of very good reasons why the CSL Limited (ASX:CSL) share price could be a buy right now. The decline looks like an attractive opportunity.
The ASX 200 (ASX:XJO) is set to fall when the market opens on Wednesday. CSL Limited (ASX:CSL) and Metcash (ASX:MTS) shares are making headlines.
The ASX 200 (ASX:XJO) is expected to rise when the market opens on Tuesday. Tilt Renewables (ASX:TLT) and Afterpay (ASX:APT) shares are making headlines.
